Rafehi M - Search Results

1

Molecular basis for stereoselective transport of fenoterol by the organic cation transporters 1 and 2.

Gebauer L, Arul Murugan N, Jensen O, Brockmöller J, Rafehi M. Gebauer L, et al. Among authors: rafehi m. Biochem Pharmacol. 2022 Mar;197:114871. doi: 10.1016/j.bcp.2021.114871. Epub 2021 Dec 10. Biochem Pharmacol. 2022. PMID: 34902340

2

Highly Variable Pharmacokinetics of Tyramine in Humans and Polymorphisms in OCT1, CYP2D6, and MAO-A.

Rafehi M, Faltraco F, Matthaei J, Prukop T, Jensen O, Grytzmann A, Blome FG, Berger RG, Krings U, Vormfelde SV, Tzvetkov MV, Brockmöller J. Rafehi M, et al. Front Pharmacol. 2019 Oct 30;10:1297. doi: 10.3389/fphar.2019.01297. eCollection 2019. Front Pharmacol. 2019. PMID: 31736764 Free PMC article.

3

Stereoselective cell uptake of adrenergic agonists and antagonists by organic cation transporters.

Jensen O, Rafehi M, Tzvetkov MV, Brockmöller J. Jensen O, et al. Among authors: rafehi m. Biochem Pharmacol. 2020 Jan;171:113731. doi: 10.1016/j.bcp.2019.113731. Epub 2019 Nov 27. Biochem Pharmacol. 2020. PMID: 31783011

4

Cellular Uptake of Psychostimulants - Are High- and Low-Affinity Organic Cation Transporters Drug Traffickers?

Jensen O, Rafehi M, Gebauer L, Brockmöller J. Jensen O, et al. Among authors: rafehi m. Front Pharmacol. 2021 Jan 20;11:609811. doi: 10.3389/fphar.2020.609811. eCollection 2020. Front Pharmacol. 2021. PMID: 33551812 Free PMC article.

5

Effects of Genetic Polymorphism in CYP2D6, CYP2C19, and the Organic Cation Transporter OCT1 on Amitriptyline Pharmacokinetics in Healthy Volunteers and Depressive Disorder Patients.

Matthaei J, Brockmöller J, Steimer W, Pischa K, Leucht S, Kullmann M, Jensen O, Ouethy T, Tzvetkov MV, Rafehi M. Matthaei J, et al. Among authors: rafehi m. Front Pharmacol. 2021 May 21;12:688950. doi: 10.3389/fphar.2021.688950. eCollection 2021. Front Pharmacol. 2021. PMID: 34093211 Free PMC article.

6

Stereoselectivity in the Membrane Transport of Phenylethylamine Derivatives by Human Monoamine Transporters and Organic Cation Transporters 1, 2, and 3.

Gebauer L, Rafehi M, Brockmöller J. Gebauer L, et al. Among authors: rafehi m. Biomolecules. 2022 Oct 18;12(10):1507. doi: 10.3390/biom12101507. Biomolecules. 2022. PMID: 36291716 Free PMC article.

7

Stereoselective Inhibition of High- and Low-Affinity Organic Cation Transporters.

Gebauer L, Jensen O, Rafehi M, Brockmöller J. Gebauer L, et al. Among authors: rafehi m. Mol Pharm. 2023 Dec 4;20(12):6289-6300. doi: 10.1021/acs.molpharmaceut.3c00691. Epub 2023 Nov 14. Mol Pharm. 2023. PMID: 37962560 Free PMC article.

8

Tools and drugs for uracil nucleotide-activated P2Y receptors.

Rafehi M, Müller CE. Rafehi M, et al. Pharmacol Ther. 2018 Oct;190:24-80. doi: 10.1016/j.pharmthera.2018.04.002. Epub 2018 Apr 13. Pharmacol Ther. 2018. PMID: 29660366 Review.

9

8-Substituted 1,3-dimethyltetrahydropyrazino[2,1-f]purinediones: Water-soluble adenosine receptor antagonists and monoamine oxidase B inhibitors.

Brunschweiger A, Koch P, Schlenk M, Rafehi M, Radjainia H, Küppers P, Hinz S, Pineda F, Wiese M, Hockemeyer J, Heer J, Denonne F, Müller CE. Brunschweiger A, et al. Among authors: rafehi m. Bioorg Med Chem. 2016 Nov 1;24(21):5462-5480. doi: 10.1016/j.bmc.2016.09.003. Epub 2016 Sep 3. Bioorg Med Chem. 2016. PMID: 27658798

10

Synthesis, characterization, and in vitro evaluation of the selective P2Y₂ receptor antagonist AR-C118925.

Rafehi M, Burbiel JC, Attah IY, Abdelrahman A, Müller CE. Rafehi M, et al. Purinergic Signal. 2017 Mar;13(1):89-103. doi: 10.1007/s11302-016-9542-3. Epub 2016 Oct 20. Purinergic Signal. 2017. PMID: 27766552 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters